The Regulation of Bone Metabolism and Disorders by Wnt Signaling
Top Cited Papers
Open Access
- 6 November 2019
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (22) , 5525
Abstract
Wnt, a secreted glycoprotein, has an approximate molecular weight of 40 kDa, and it is a cytokine involved in various biological phenomena including ontogeny, morphogenesis, carcinogenesis, and maintenance of stem cells. The Wnt signaling pathway can be classified into two main pathways: canonical and non-canonical. Of these, the canonical Wnt signaling pathway promotes osteogenesis. Sclerostin produced by osteocytes is an inhibitor of this pathway, thereby inhibiting osteogenesis. Recently, osteoporosis treatment using an anti-sclerostin therapy has been introduced. In this review, the basics of Wnt signaling, its role in bone metabolism and its involvement in skeletal disorders have been covered. Furthermore, the clinical significance and future scopes of Wnt signaling in osteoporosis, osteoarthritis, rheumatoid arthritis and neoplasia are discussed.Keywords
Funding Information
- the Ministry of Education, Cultures, Sports, Science and Technology of Japan (18K16161)
This publication has 226 references indexed in Scilit:
- Crosstalk between Wnt/β-Catenin and Estrogen Receptor Signaling Synergistically Promotes Osteogenic Differentiation of Mesenchymal Progenitor CellsPLOS ONE, 2013
- Lrp5 and Lrp6 Exert Overlapping Functions in Osteoblasts during Postnatal Bone AcquisitionPLOS ONE, 2013
- WNT1 Mutations in Early-Onset Osteoporosis and Osteogenesis ImperfectaNew England Journal of Medicine, 2013
- Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fractureNature Genetics, 2012
- Noncanonical Wnt signaling promotes osteoclast differentiation and is facilitated by the human immunodeficiency virus protease inhibitor ritonavirBiochemical and Biophysical Research Communications, 2012
- Lrp5 functions in bone to regulate bone massNature Medicine, 2011
- LRP4 Mutations Alter Wnt/β-Catenin Signaling and Cause Limb and Kidney Malformations in Cenani-Lenz SyndromeThe American Journal of Human Genetics, 2010
- Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studiesNature Genetics, 2009
- Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the DuodenumCell, 2008
- Lrp4 Is a Receptor for Agrin and Forms a Complex with MuSKCell, 2008